An internationally recognized uniform cytogenetic classification system is needed for multiple myeloma.
Dispenzieri
A
A
D001897:Boronic Acids / Q000627:therapeutic use; D000069286:Bortezomib; D002869:Chromosome Aberrations; D020732:Cytogenetic Analysis / Q000379:methods; D006801:Humans; D009101:Multiple Myeloma / Q000145:classification / Q000188:drug therapy / Q000235:genetics; D011237:Predictive Value of Tests; D011379:Prognosis; D011719:Pyrazines / Q000627:therapeutic use
D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib